Weiwen Ying

1.3k total citations
27 papers, 973 citations indexed

About

Weiwen Ying is a scholar working on Molecular Biology, Organic Chemistry and Pharmaceutical Science. According to data from OpenAlex, Weiwen Ying has authored 27 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Pharmaceutical Science. Recurrent topics in Weiwen Ying's work include Heat shock proteins research (13 papers), ATP Synthase and ATPases Research (4 papers) and Computational Drug Discovery Methods (3 papers). Weiwen Ying is often cited by papers focused on Heat shock proteins research (13 papers), ATP Synthase and ATPases Research (4 papers) and Computational Drug Discovery Methods (3 papers). Weiwen Ying collaborates with scholars based in United States and China. Weiwen Ying's co-authors include Kevin P. Foley, James Barsoum, Keizo Koya, Takayo Inoue, Lijun Sun, Misty D. Bear, Cheryl A. London, Zhenjian Du, Jim Sang and Luisa Shin Ogawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Weiwen Ying

26 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiwen Ying United States	16	658	188	162	113	109	27	973
Yeong Sang Kim United States	13	614 0.9×	70 0.4×	134 0.8×	179 1.6×	191 1.8×	17	863
Gregg Timony United States	11	545 0.8×	107 0.6×	142 0.9×	73 0.6×	28 0.3×	24	882
Rachel Kroe‐Barrett United States	19	654 1.0×	103 0.5×	231 1.4×	107 0.9×	30 0.3×	34	1.1k
Wen‐Cherng Lee United States	15	627 1.0×	132 0.7×	175 1.1×	224 2.0×	58 0.5×	21	1000
Alexander Gozman United States	8	612 0.9×	61 0.3×	119 0.7×	120 1.1×	52 0.5×	22	778
Andrew L. MacKinnon United States	10	963 1.5×	128 0.7×	151 0.9×	220 1.9×	86 0.8×	16	1.4k
Noriaki Tatsuta United States	12	426 0.6×	123 0.7×	103 0.6×	125 1.1×	66 0.6×	21	731
Martin H. Hager United States	13	1.1k 1.7×	281 1.5×	107 0.7×	156 1.4×	175 1.6×	18	1.6k
Maria Vilenchik United States	11	723 1.1×	40 0.2×	95 0.6×	133 1.2×	39 0.4×	20	931
Erin Joseph United States	17	584 0.9×	56 0.3×	66 0.4×	228 2.0×	61 0.6×	31	985

Countries citing papers authored by Weiwen Ying

Since Specialization

Citations

This map shows the geographic impact of Weiwen Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwen Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwen Ying more than expected).

Fields of papers citing papers by Weiwen Ying

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwen Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwen Ying. The network helps show where Weiwen Ying may publish in the future.

Co-authorship network of co-authors of Weiwen Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwen Ying. A scholar is included among the top collaborators of Weiwen Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwen Ying. Weiwen Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Proia, David A., Donald L. Smith, Junyi Zhang, et al.. (2015). HSP90 Inhibitor–SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors. Molecular Cancer Therapeutics. 14(11). 2422–2432. 29 indexed citations

Wang, Junmei, Weiwen Ying, Daxing Tang, et al.. (2015). Prognostic value of three-dimensional ultrasound for fetal hydronephrosis. Experimental and Therapeutic Medicine. 9(3). 766–772. 2 indexed citations

Liu, Yuan, Luisa Shin Ogawa, Takayo Inoue, et al.. (2015). The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus. PLoS ONE. 10(5). e0127361–e0127361. 10 indexed citations

Qin, Jiale, Weiwen Ying, Xiaodong Cheng, et al.. (2014). A Well-Circumscribed Border with Peripheral Doppler Signal in Sonographic Image Distinguishes Epithelioid Trophoblastic Tumor from Other Gestational Trophoblastic Neoplasms. PLoS ONE. 9(11). e112618–e112618. 17 indexed citations

Ying, Weiwen, Dinesh Chimmanamada, Junyi Zhang, et al.. (2014). Abstract 1619: Hsp90 inhibitor drug conjugates (HDCs): Construct design and preliminary evaluation. Cancer Research. 74(19_Supplement). 1619–1619. 2 indexed citations

McCready, Jessica, Daniel S. Wong, Joseph A. Burlison, Weiwen Ying, & Daniel G. Jay. (2014). An Impermeant Ganetespib Analog Inhibits Extracellular Hsp90-Mediated Cancer Cell Migration that Involves Lysyl Oxidase 2-like Protein. Cancers. 6(2). 1031–1046. 35 indexed citations

Seeger‐Nukpezah, Tamina, David A. Proia, Brian L. Egleston, et al.. (2013). Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease. Proceedings of the National Academy of Sciences. 110(31). 12786–12791. 37 indexed citations

Zhou, Dan, Yuan Liu, Weiwen Ying, et al.. (2013). A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors. Toxicology and Applied Pharmacology. 273(2). 401–409. 56 indexed citations

Giubellino, Alessio, Carole Sourbier, Petra Bullova, et al.. (2013). Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma. PLoS ONE. 8(2). e56083–e56083. 21 indexed citations

10.

Shimamura, Takeshi, Samanthi A. Perera, Kevin P. Foley, et al.. (2012). Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer. Clinical Cancer Research. 18(18). 4973–4985. 131 indexed citations

11.

Ying, Weiwen, Zhenjian Du, Lijun Sun, et al.. (2011). Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy. Molecular Cancer Therapeutics. 11(2). 475–484. 181 indexed citations

12.

London, Cheryl A., Misty D. Bear, Kevin P. Foley, et al.. (2011). Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer. PLoS ONE. 6(11). e27018–e27018. 32 indexed citations

13.

Zhou, Dan, Yuan Liu, Weiwen Ying, et al.. (2011). Abstract C212: A critical role for the tissue distribution profile in heat shock protein (Hsp) 90 inhibitor-induced ocular toxicity in rats.. Molecular Cancer Therapeutics. 10(11_Supplement). C212–C212. 8 indexed citations

14.

Bear, Misty D., Stacey Fossey, Robert Mihalek, et al.. (2009). The novel HSP90 inhibitor STA‐1474 exhibits biologic activity against osteosarcoma cell lines. International Journal of Cancer. 125(12). 2792–2801. 62 indexed citations

15.

Bear, Misty D., et al.. (2008). The novel HSP90 inhibitor STA-9090 exhibits activity against Kit dependent and independent malignant mast cell tumors.. Cancer Research. 68. 5638–5638. 2 indexed citations

16.

Lin, Tzu‐yin, Misty D. Bear, Zhenjian Du, et al.. (2008). The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors. Experimental Hematology. 36(10). 1266–1277. 88 indexed citations

17.

James, David A., Keizo Koya, Hao Li, et al.. (2008). Indole- and indolizine-glyoxylamides displaying cytotoxicity against multidrug resistant cancer cell lines. Bioorganic & Medicinal Chemistry Letters. 18(6). 1784–1787. 89 indexed citations

18.

James, David A., Keizo Koya, Hao Li, et al.. (2006). Conjugated indole-imidazole derivatives displaying cytotoxicity against multidrug resistant cancer cell lines. Bioorganic & Medicinal Chemistry Letters. 16(19). 5164–5168. 35 indexed citations

19.

Ying, Weiwen, Darryl D. DesMarteau, & Yoshihiko Gotoh. (1996). N-fluoro-bis[(trifluoromethyl)sulfonyl]imide: Electrophilic fluorination of imines and some methyl-substituted pyridines. Tetrahedron. 52(1). 15–22. 46 indexed citations

20.

Huang, Wei‐Yuan, et al.. (1993). Further study on the synthesis of F‐containing porphyrins and their catalytic activity on oxidation of cyclohexene. Chinese Journal of Chemistry. 11(5). 464–471. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact